TY - JOUR
T1 - Latent classes of trial reporting and publication practices in spinal manipulation research
T2 - a meta-epidemiological study
AU - Nim, Casper
AU - Frederiksen, Michelle
AU - Aspinall, Sasha
AU - Downie, Aron
AU - Funabashi, Martha
AU - Harsted, Steen
AU - Jenkins, Hazel
AU - McNaughton, David
AU - Nyirö, Luana
AU - Roseen, Eric J
AU - Young, James J
AU - Dennett, Liz
AU - Perle, Stephen M
AU - Cook, Chad
AU - Juhl, Carsten
AU - Hartvigsen, Jan
N1 - Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2026/2
Y1 - 2026/2
N2 - BACKGROUND: Reliable reporting and publication practices are essential for trustworthy evidence synthesis and clinical decision-making.OBJECTIVE: We aimed to identify latent classes of randomized controlled trials (RCTs) evaluating spinal manipulative therapy (SMT) based on trial reporting and publication practices, and to examine whether these classes influenced treatment effects.DESIGN: Meta-epidemiological study.METHOD: Trials were evaluated on whether they met criteria for trial reporting and publication practices across six domains. Latent class analysis was used to identify trial subgroups. Random-effects meta-regression models assessed whether class membership predicted pooled estimates of treatment effects for pain and disability.RESULTS: We included 239 RCTs and identified four classes: Dated (23 %), older trials (mostly pre-2010) with consistently low proportions of criteria met; Non-contributing (30 %), newer trials that inconsistently met the criteria, had small samples, and short follow-ups; SMT-focused (15 %), which reported SMT details and fidelity more consistently but otherwise resembled the Non-contributing class; and Pragmatic (33 %), consisting of larger trials, meeting most criteria, but often underreported SMT-specific and fidelity details. Reporting practices had larger impact on class membership than publication practices. Despite differences class membership was not associated with treatment effect estimates and explained minimal outcome variability (R2 ∼1 %).CONCLUSIONS: Although trial reporting and publication practices varied substantially across SMT trials, these differences were not associated with differences in treatment effects. The widespread failure to meet key criteria raises concerns about the interpretability and credibility of the SMT evidence base. To strengthen transparency and scientific value, future trials should adhere more rigorously to reporting guidelines.
AB - BACKGROUND: Reliable reporting and publication practices are essential for trustworthy evidence synthesis and clinical decision-making.OBJECTIVE: We aimed to identify latent classes of randomized controlled trials (RCTs) evaluating spinal manipulative therapy (SMT) based on trial reporting and publication practices, and to examine whether these classes influenced treatment effects.DESIGN: Meta-epidemiological study.METHOD: Trials were evaluated on whether they met criteria for trial reporting and publication practices across six domains. Latent class analysis was used to identify trial subgroups. Random-effects meta-regression models assessed whether class membership predicted pooled estimates of treatment effects for pain and disability.RESULTS: We included 239 RCTs and identified four classes: Dated (23 %), older trials (mostly pre-2010) with consistently low proportions of criteria met; Non-contributing (30 %), newer trials that inconsistently met the criteria, had small samples, and short follow-ups; SMT-focused (15 %), which reported SMT details and fidelity more consistently but otherwise resembled the Non-contributing class; and Pragmatic (33 %), consisting of larger trials, meeting most criteria, but often underreported SMT-specific and fidelity details. Reporting practices had larger impact on class membership than publication practices. Despite differences class membership was not associated with treatment effect estimates and explained minimal outcome variability (R2 ∼1 %).CONCLUSIONS: Although trial reporting and publication practices varied substantially across SMT trials, these differences were not associated with differences in treatment effects. The widespread failure to meet key criteria raises concerns about the interpretability and credibility of the SMT evidence base. To strengthen transparency and scientific value, future trials should adhere more rigorously to reporting guidelines.
KW - Humans
KW - Manipulation, Spinal/methods
KW - Randomized Controlled Trials as Topic
KW - Research Design/standards
KW - Epidemiologic Studies
KW - Male
U2 - 10.1016/j.msksp.2025.103480
DO - 10.1016/j.msksp.2025.103480
M3 - Review
C2 - 41468809
SN - 2468-7812
VL - 81
SP - 103480
JO - Musculoskeletal science & practice
JF - Musculoskeletal science & practice
M1 - 103480
ER -